Trung Huynh
Stock Analyst at UBS
(2.02)
# 1161
Out of 5,368 analysts
45
Total ratings
55.56%
Success rate
26.15%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Neutral | 633 560 | 529.27 | 5.81% | 3 | Jun 5, 2025 | |
JSPR Jasper Therapeutics | Maintains: Buy | 38 33 | 5.54 | 495.67% | 2 | May 13, 2025 | |
CLDX Celldex Therapeutics | Maintains: Buy | 44 38 | 21.24 | 78.91% | 2 | May 9, 2025 | |
INSM Insmed | Maintains: Buy | 110 109 | 98.8 | 10.32% | 5 | May 9, 2025 | |
AMGN Amgen | Maintains: Neutral | 319 315 | 295.15 | 6.73% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1100 1050 | 819.67 | 28.1% | 8 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 25 | 24.52 | 1.96% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 54 | 49.73 | 8.59% | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 7 | 1.99 | 251.76% | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 13 | 3.21 | 304.98% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 170 175 | 157.04 | 11.44% | 2 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 126 | 81.72 | 54.19% | 3 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 170 | 190.93 | -10.96% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Mar 23, 2021 |